Peng Gong
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 14
- Lung Cancer Research Studies 7
- Cancer Cells and Metastasis 6
- Cancer Research top 10%
- Physiology top 10%
-
- RNA modifications and cancer 7
- Genomics, phytochemicals, and oxidative stress 4
- Hepatology top 10%
-
- Neuroendocrine Tumor Research Advances 8
- Liver Disease Diagnosis and Treatment 5
-
- Nanoplatforms for cancer theranostics 4
Peng Gong
66 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 111
- Oncology 399
- Cancer Research 216
- Physiology 31
- Molecular Biology 467
- Hepatology 53
Countries citing papers authored by Peng Gong
This map shows the geographic impact of Peng Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Gong more than expected).
Fields of papers citing papers by Peng Gong
This network shows the impact of papers produced by Peng Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Gong. The network helps show where Peng Gong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peng Gong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 15 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 41 | |
| 7 | 2023 | 1 | |
| 8 | 2021 | 31 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2019 | 3 | |
| 12 | 2018 | 1 | |
| 13 | 2018 | 14 | |
| 14 | 2017 | 11 | |
| 15 | 2016 | 98 | |
| 16 | 2013 | 34 | |
| 17 | PPAR expression and its association with SOD and NF-?B in rats with obstructive jaundice | 2012 | 7 |
| 18 | PCR-based detection of Wolbachia infected in natural populations of wheat aphids in China | 2002 | 1 |
| 19 | Experimental study on myocardial injury and the protective effects of tetramethylpyrazine after biliary obstruction | 2001 | 1 |
| 20 | Microsatellite DNA polymorphism in different forms of the cotton aphid | 2001 | 3 |
About Peng Gong
Peng Gong is a scholar working on Oncology, Cancer Research and Hepatology, having authored 68 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (14 papers), Neuroendocrine Tumor Research Advances (8 papers), RNA modifications and cancer (7 papers), Lung Cancer Research Studies (7 papers), Cancer Cells and Metastasis (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Oncology (399 citations), Cancer Research (216 citations) and Physiology (31 citations). Peng Gong has collaborated with scholars based in China, Germany and Singapore. Frequent co-authors include Xianbin Zhang, Haidong Bao, Ke Jiang, Zhongyu Wang, Songshu Meng, Yuru Shang, Xin Dong, Peng Liu, Yumei Yan and Wei Bi. Their work appears in journals such as Journal of Advanced Research, BMC Endocrine Disorders, International Journal of Surgery, Scientific Reports and Frontiers in bioscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.